4.0 Article

Interleukin-6 plasma level increases with age in an Italian elderly population (The Treviso LongevaaEuroTrelong-study) with a sex-specific contribution of rs1800795 polymorphism

Journal

AGE
Volume 31, Issue 2, Pages 155-162

Publisher

SPRINGER
DOI: 10.1007/s11357-009-9092-5

Keywords

IL-6; Longevity; Rs1800795; Immunosenescence; Inflammation; Sex

Funding

  1. Veneto Region
  2. Treviso Municipality, Treviso Province and Cassamarca Foundation
  3. Monzino Foundation (Milan, Italy)
  4. Centro Dino Ferrari (Milan, Italy)
  5. Golgi Cenci Foundation, Milan, Italy

Ask authors/readers for more resources

The transcription rate of interleukin-6 (IL-6) can be reduced by the C-allele of a polymorphism (rs1800795) located in the 5'-flanking region of the IL-6 gene (NM_000600), and IL-6 plasma levels increase with age. We assembled an elderly Italian population [The Treviso Longeva (Trelong) study, age range 70-106 years, n = 668 subjects] and assessed rs1800795 genotype and plasma IL-6 concentrations. The rs1800795 genotype was also assessed in an independent Italian study (Milan study, age range 70-96, n = 245 subjects). To verify an age- or sex-specific effect of rs1800795 genotype we compared people younger (70-85) and older (85+) than 85 years of age. We found a significant reduction in the frequency of rs1800795 C/C genotype in 85+ men from the Trelong study, while in the Milan study this data did not reach significance. However, considering the two studies together, the frequency of the rs1800795 C/C genotype was significantly lower in 85+ than in 70-85 males (4.0% and 10.7%, respectively), while it remained unchanged in females. As for IL-6 plasma levels, after a multivariate analysis to control for confounders, a correlation between age and plasma IL-6 concentrations was revealed (P < 0.0001). An increase in circulating IL-6 levels in the entire 85+ group compared to the 70-85 group (P < 0.05, Tukey's test) was also noticed. We suggest a sex-specific pattern for genetic variability linked to inflammatory response and longevity, consistent with the age-related increase in IL-6.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Clinical Neurology

QEEG abnormalities in cognitively unimpaired patients with delirium

Claudia Carrarini, Dario Calisi, Matteo Alessandro De Rosa, Angelo Di Iorio, Damiano D'Ardes, Raffaello Pellegrino, Stefano Gazzina, Andrea Pilotto, Andrea Arighi, Tiziana Carandini, Annachiara Cagnin, Stefano Mozzetta, Maurizio Gallucci, Domenico Marco Bonifati, Cinzia Costa, Fabrizia D'Antonio, Giuseppe Bruno, Francesco Cipollone, Claudio Babiloni, Alessandro Padovani, Marco Onofrj, Laura Bonanni

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Article Clinical Neurology

Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia

David J. Whiteside, Maura Malpetti, P. Simon Jones, Boyd C. P. Ghosh, Ian Coyle-Gilchrist, John C. van Swieten, Harro Seelaar, Lize Jiskoot, Barbara Borroni, Raquel Sanchez-Valle, Fermin Moreno, Robert Laforce, Caroline Graff, Matthis Synofzik, Daniela Galimberti, Mario Masellis, Maria Carmela Tartaglia, Elizabeth Finger, Rik Vandenberghe, Alexandre de Mendonca, Fabrizio Tagliavini, Chris R. Butler, Isabel Santana, Isabelle Le Ber, Alexander Gerhard, Simon Ducharme, Johannes Levin, Adrian Danek, Markus Otto, Sandro Sorbi, Florence Pasquier, Arabella Bouzigues, Lucy L. Russell, Jonathan D. Rohrer, James B. Rowe, Timothy Rittman

Summary: This study investigated the role of changes in functional networks in predicting cognitive decline and conversion to symptomatic disease in familial frontotemporal dementia (FTD). The study found a characteristic pattern of dynamic network changes in FTD, which were correlated with neuropsychological impairment. Among presymptomatic mutation carriers, this pattern of network dynamics was more prominent in those who later converted to the symptomatic phase. Baseline network dynamic changes predicted future cognitive decline in symptomatic participants and older presymptomatic participants.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers

Elizabeth Finger, Rubina Malik, Martina Bocchetta, Kristy Coleman, Caroline Graff, Barbara Borroni, Mario Masellis, Robert Laforce, Caroline Greaves, Lucy L. Russell, Rhian S. Convery, Arabella Bouzigues, David M. Cash, Markus Otto, Matthis Synofzik, James B. Rowe, Daniela Galimberti, Pietro Tiraboschi, Robert Bartha, Christen Shoesmith, Maria Carmela Tartaglia, John C. van Swieten, Harro Seelaar, Lize C. Jiskoot, Sandro Sorbi, Chris R. Butler, Alexander Gerhard, Raquel Sanchez-Valle, Alexandre de Mendonca, Fermin Moreno, Rik Vandenberghe, Isabelle Le Ber, Johannes Levin, Florence Pasquier, Isabel Santana, Jonathan D. Rohrer, Simon Ducharme

Summary: This study investigates the hypothesis that genetic mutations causing frontotemporal dementia (FTD) have neurodevelopmental consequences. The researchers examined brain structure and function in young adult mutation carriers and found differences between preclinical mutation carriers and familial non-carriers at a mean age of 26 years. These findings have implications for therapeutic interventions and further studies on early pathophysiologic processes in FTD.

BRAIN (2023)

Article Clinical Neurology

Language impairment in the genetic forms of behavioural variant frontotemporal dementia

Kiran Samra, Amy M. MacDougall, Arabella Bouzigues, Martina Bocchetta, David M. Cash, Caroline Greaves, Rhian S. Convery, John C. van Swieten, Harro Seelaar, Lize Jiskoot, Fermin Moreno, Raquel Sanchez-Valle, Robert Laforce, Caroline Graff, Mario Masellis, Maria Carmela Tartaglia, James B. Rowe, Barbara Borroni, Elizabeth Finger, Matthis Synofzik, Daniela Galimberti, Rik Vandenberghe, Alexandre de Mendonca, Christopher R. Butler, Alexander Gerhard, Simon Ducharme, Isabelle Le Ber, Pietro Tiraboschi, Isabel Santana, Florence Pasquier, Johannes Levin, Markus Otto, Sandro Sorbi, Jonathan D. Rohrer, Lucy L. Russell

Summary: The study found that about 76% of patients with genetic bvFTD have language impairments, characterized by impaired functional communication, decreased fluency, and impaired sentence comprehension. There are differences in the extent of brain atrophy in specific language regions and language symptoms among different genetic types of patients. This research is helpful for further understanding the language phenotype associated with genetic bvFTD, especially in accurate stratification and monitoring of disease progression in clinical trials.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study

Agnes Perez-Millan, Sergi Borrego-Ecija, John C. van Swieten, Lize Jiskoot, Fermin Moreno, Robert Laforce, Caroline Graff, Mario Masellis, Maria Carmela Tartaglia, James B. Rowe, Barbara Borroni, Elizabeth Finger, Matthis Synofzik, Daniela Galimberti, Rik Vandenberghe, Alexandre de Mendonca, Chris R. Butler, Alexander Gerhard, Simon Ducharme, Isabelle Le Ber, Isabel Santana, Florence Pasquier, Johannes Levin, Markus Otto, Sandro Sorbi, Pietro Tiraboschi, Harro Seelaar, Tobias Langheinrich, Jonathan D. Rohrer, Roser Sala-Llonch, Raquel Sanchez-Valle

Summary: The C9orf72 expansion is a common genetic cause of frontotemporal dementia and/or motor neuron disease. MRI analysis showed differences in white matter volumes between presymptomatic and symptomatic carriers, suggesting that this measure may be useful in predicting symptom onset. Additionally, clinical severity was negatively associated with white matter volume.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

Kiran Samra, Amy M. MacDougall, Georgia Peakman, Arabella Bouzigues, Martina Bocchetta, David M. Cash, Caroline Greaves, Rhian S. Convery, John C. van Swieten, Lize Jiskoot, Harro Seelaar, Fermin Moreno, Raquel Sanchez-Valle, Robert Laforce, Caroline Graff, Mario Masellis, Carmela Tartaglia, James B. Rowe, Barbara Borroni, Elizabeth Finger, Matthis Synofzik, Daniela Galimberti, Rik Vandenberghe, Alexandre de Mendonca, Chris R. Butler, Alexander Gerhard, Simon Ducharme, Isabelle Le Ber, Pietro Tiraboschi, Isabel Santana, Florence Pasquier, Johannes Levin, Markus Otto, Sandro Sorbi, Jonathan D. Rohrer, Lucy L. Russell

Summary: This study investigated the optimal method of adding motor features to a clinical rating scale for frontotemporal dementia (FTD). The results showed that motor symptoms are present in mutation carriers at all disease stages, and including motor symptoms in a rating scale can provide a more accurate assessment of disease severity and incorporate a wider spectrum of FTD phenotypes in the same clinical trial.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

The Benson Complex Figure Test detects deficits in visuoconstruction and visual memory in symptomatic familial frontotemporal dementia: A GENFI study

Lize C. Jiskoot, Lucy L. Russell, Georgia Peakman, Rhian S. Convery, Caroline V. Greaves, Martina Bocchetta, Jackie M. Poos, Harro Seelaar, Lucia A. A. Giannini, John C. van Swieten, Rick van Minkelen, Yolande A. L. Pijnenburg, James B. Rowe, Barbara Borroni, Daniela Galimberti, Mario Masellis, Carmela Tartaglia, Elizabeth Finger, Chris R. Butler, Caroline Graff, Robert Laforce Jr, Raquel Sanchez-Valle, Alexandre de Mendonca, Fermin Moreno, Matthis Synofzik, Rik Vandenberghe, Simon Ducharme, Isabelle le Ber, Johannes Levin, Markus Otto, Florence Pasquier, Isabel Santana, David M. Cash, David Thomas, Jonathan D. Rohrer

Summary: The Benson Complex Figure Test (BCFT) shows potential as a sensitive cognitive marker for frontotemporal dementia (FTD). Differences were found in BCFT Copy, Recall, and Recognition scores between presymptomatic and symptomatic FTD mutation carriers, with correlations to cognitive function and neuroimaging results. These findings suggest limited potential of BCFT as a cognitive biomarker for upcoming clinical trials in presymptomatic to early-stage FTD.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2023)

Article Clinical Neurology

Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease

Marta Turri, Elisa Conti, Chiara Pavanello, Francesco Gastoldi, Marcella Palumbo, Franco Bernini, Vittoria Aprea, Francesca Re, Alberto Barbiroli, Davide Emide, Daniela Galimberti, Lucio Tremolizzo, Francesca Zimetti, Laura Calabresi, AGAINST AD Grp

Summary: The purpose of this study was to evaluate cholesterol esterification and HDL subclasses in plasma and cerebrospinal fluid (CSF) of Alzheimer's disease (AD) patients. The results showed that cholesterol esterification efficiency was reduced in the plasma of AD patients, and the unesterified cholesterol ratio was increased in CSF.

ALZHEIMERS RESEARCH & THERAPY (2023)

Review Chemistry, Multidisciplinary

Why Is Multiple Sclerosis More Frequent in Women? Role of the Immune System and of Oral and Gut Microbiota

Marianna D'Anca, Francesca R. Buccellato, Gianluca Martino Tartaglia, Massimo Del Fabbro, Paola Muti, Elio Scarpini, Daniela Galimberti, Laura Ghezzi

Summary: Multiple sclerosis (MS), a prevalent demyelinating disease of the central nervous system, primarily affects young adults. The autoimmune response of lymphocyte cells against myelin components leads to inflammation, demyelination, and axonal degeneration. Gender-related factors, such as sex hormones and genetic differences, contribute to the higher prevalence in women. Dysbiosis of gut microbiota and oral biology alterations may also play a role in the pathogenesis. This study aims to explore gender differences in MS and their potential involvement in the oral-gut-brain axis.

APPLIED SCIENCES-BASEL (2023)

Article Medicine, General & Internal

Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease

Jiao Luo, Jesper Qvist Thomassen, Celine Bellenguez, Benjamin Grenier-Boley, Itziar de Rojas, Atahualpa Castillo, Kayenat Parveen, Fahri Kuecuekali, Aude Nicolas, Oliver Peters, Anja Schneider, Martin Dichgans, Dan Rujescu, Norbert Scherbaum, Deckert Juergen, Steffi Riedel-Heller, Lucrezia Hausner, Laura Molina Porcel, Emrah Duezel, Timo Grimmer, Jens Wiltfang, Stefanie Heilmann-Heimbach, Susanne Moebus, Thomas Tegos, Nikolaos Scarmeas, Jordi Clarimon, Fermin Moreno, Jordi Perez-Tur, Maria J. Bullido, Pau Pastor, Raquel Sanchez-Valle, Victoria Alvarez, Merce Boada, Pablo Garcia-Gonzalez, Raquel Puerta, Pablo Mir, Luis M. Real, Gerard Pinol-Ripoll, Jose Maria Garcia-Alberca, Jose Luis Royo, Eloy Rodriguez-Rodriguez, Hilkka Soininen, Teemu Kuulasmaa, Alexandre de Mendonca, Shima Mehrabian, Jakub Hort, Martin Vyhnalek, Sven van der Lee, Caroline Graff, Goran Papenberg, Vilmantas Giedraitis, Anne Boland, Delphine Bacq-Daian, Jean-Francois Deleuze, Gael Nicolas, Carole Dufouil, Florence Pasquier, Olivier Hanon, Stephanie Debette, Edna Gruenblatt, Julius Popp, Luisa Benussi, Daniela Galimberti, Beatrice Arosio, Patrizia Mecocci, Vincenzo Solfrizzi, Lucilla Parnetti, Alessio Squassina, Lucio Tremolizzo, Barbara Borroni, Benedetta Nacmias, Sandro Sorbi, Paolo Caffarra, Davide Seripa, Innocenzo Rainero, Antonio Daniele, Carlo Masullo, Gianfranco Spalletta, Julie Williams, Philippe Amouyel, Frank Jessen, Patrick Kehoe, Tsolaki Magda, Giacomina Rossi, Pascual Sanchez-Juan, Kristel Sleegers, Martin Ingelsson, Ole A. Andreassen, Mikko Hiltunen, Cornelia Van Duijn, Rebecca Sims, Wiesje van der Flier, Agustin Ruiz, Alfredo Ramirez, Jean-Charles Lambert, Ruth Frikke-Schmidt

Summary: This genetic association study identifies novel genetic associations between high HDL cholesterol concentrations and high systolic blood pressure with increased risk of AD, potentially inspiring new drug targeting and improved prevention implementation.

JAMA NETWORK OPEN (2023)

Article Clinical Neurology

Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: comparison with sporadic primary progressive aphasia

Kiran Samra, Amy M. MacDougall, Arabella Bouzigues, Martina Bocchetta, David M. Cash, Caroline Greaves, Rhian S. Convery, Chris Hardy, John C. van Swieten, Harro Seelaar, Lize C. Jiskoot, Fermin Moreno, Raquel Sanchez-Valle, Robert Laforce, Caroline Graff, Mario Masellis, Maria Carmela Tartaglia, James B. Rowe, Barbara Borroni, Elizabeth Finger, Matthis Synofzik, Daniela Galimberti, Rik Vandenberghe, Alexandre de Mendonca, Chris R. Butler, Alexander Gerhard, Simon Ducharme, Isabelle Le Ber, Isabel Santana, Florence Pasquier, Johannes Levin, Markus Otto, Sandro Sorbi, Jason D. Warren, Jonathan D. Rohrer, Lucy L. Russell

Summary: Samra et al. report that progranulin mutations are the most common genetic cause of primary progressive aphasia, with two subtypes observed. Revised criteria for primary progressive aphasia should take into account genetic phenotypes. Primary progressive aphasia is typically sporadic, but can also be genetic.

BRAIN COMMUNICATIONS (2023)

Article Clinical Neurology

Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort

Martina Bocchetta, Emily G. Todd, Arabella Bouzigues, David M. Cash, Jennifer M. Nicholas, Rhian S. Convery, Lucy L. Russell, David L. Thomas, Ian B. Malone, Juan Eugenio Iglesias, John C. van Swieten, Lize C. Jiskoot, Harro Seelaar, Barbara Borroni, Daniela Galimberti, Raquel Sanchez-Valle, Robert Laforce, Fermin Moreno, Matthis Synofzik, Caroline Graff, Mario Masellis, Maria Carmela Tartaglia, James B. Rowe, Rik Vandenberghe, Elizabeth Finger, Fabrizio Tagliavini, Alexandre de Mendonca, Isabel Santana, Chris R. Butler, Simon Ducharme, Alexander Gerhard, Adrian Danek, Johannes Levin, Markus Otto, Sandro Sorbi, Isabelle Le Ber, Florence Pasquier, Jonathan D. Rohrer

Summary: The study quantified brain anomalies on MRI in individuals with C9orf72, MAPT, and GRN mutations. The identified imaging markers associated with clinical and behavioral changes in presymptomatic carriers over one year, providing important data for participant stratification in trials. Biomarkers predicting disease progression in genetic frontotemporal dementia are urgently needed.

BRAIN COMMUNICATIONS (2023)

Article Neurosciences

A Multimodal Approach for Clinical Diagnosis and Treatment of Primary Progressive Aphasia (MAINSTREAM): A Study Protocol

Maria Cotelli, Francesca Baglio, Rosa Manenti, Valeria Blasi, Daniela Galimberti, Elena Gobbi, Ilaria Pagnoni, Federica Rossetto, Emanuela Rotondo, Valentina Esposito, Roberto De Icco, Carla Giudice, Cristina Tassorelli, Eleonora Catricala, Giulia Perini, Cristina Alaimo, Elena Campana, Luisa Benussi, Roberta Ghidoni, Giuliano Binetti, Tiziana Carandini, Stefano Francesco Cappa

Summary: Primary Progressive Aphasia (PPA) is a syndrome caused by different neurodegenerative disorders that disrupt language functions. There is a lack of specialized care for PPA, with few specialists and dedicated services for diagnosis and continuing care. Current healthcare systems struggle to provide adequate and coordinated care for PPA patients and their families. Non-invasive brain stimulation techniques like transcranial Direct Current Stimulation (tDCS) have gained attention as personalized treatment options, and the MAINSTREAM trial aims to introduce and evaluate these therapeutic innovations coupled with language therapy in rehabilitation settings.

BRAIN SCIENCES (2023)

Review Dentistry, Oral Surgery & Medicine

Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation

Paola Dongiovanni, Marica Meroni, Sara Casati, Riccardo Goldoni, Douglas Vieira Thomaz, Nermin Seda Kehr, Daniela Galimberti, Massimo Del Fabbro, Gianluca M. Tartaglia

Summary: Chronic disorders such as type 2 diabetes, obesity, heart disease, and cancer are preceded by chronic low-grade inflammation. Saliva, which can be easily collected and stored, contains biomarkers that can indicate the presence of chronic diseases. This review discusses the advantages and challenges of using standard and cutting-edge techniques to discover salivary biomarkers that can be used for diagnosis and therapy of chronic diseases.

INTERNATIONAL JOURNAL OF ORAL SCIENCE (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis

Anna M. Pietroboni, Annalisa Colombi, Valeria E. Contarino, Francesco Maria Lo Russo, Giorgio Conte, Aurelia Morabito, Silvia Siggillino, Tiziana Carandini, Chiara Fenoglio, Andrea Arighi, Milena A. De Riz, Marina Arcaro, Luca Sacchi, Giorgio G. Fumagalli, Anna Maria Bianchi, Fabio Triulzi, Elio Scarpini, Daniela Galimberti

Summary: This study investigated the susceptibility of normal-appearing white matter (NAWM) in newly diagnosed multiple sclerosis (MS) patients and found that quantitative susceptibility mapping (QSM) in the NAWM can predict the increment of the expanded disability status scale (EDSS) over time. This finding may help identify patients at an increased risk of early disability progression.

EUROPEAN RADIOLOGY (2023)

No Data Available